Can a simple nudge get ovarian cancer patients to the right specialist faster?

NCT ID NCT06451263

Ongoing Knowledge-focused Sponsor: Abramson Cancer Center at Penn Medicine Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a gentle reminder to doctors can increase referrals to gynecologic oncology for women with suspicious ovarian masses. Researchers will send a message to ordering providers within 48 hours of imaging results, encouraging them to refer patients. The study includes 20 women and compares results to past patients to see if the nudge helps more women see a specialist within 30 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nudge (behavioral intervention)
What this could lead to: If successful, this could show that a simple reminder helps more patients see a specialist quickly, potentially improving ovarian cancer outcomes.
What could go wrong: This is a small pilot study with only 20 participants, so results may not apply broadly. It tests a process, not a treatment, so direct health benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fallopian tube cancer fallopian tube neoplasm ovarian cancer peritoneum cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FALLOPIAN TUBE CANCER OVARIAN CANCER PERITONEAL CANCER

Contacts and locations

Locations

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.